You are here

Home

Clinical Trials: Nervous System Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, August 15, 2017 - 19:00
Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease
Condition:   Huntington Disease
Interventions:   Biological: Cellavita HD lower dose;   Biological: Cellavita HD higher dose;   Other: Placebo
Sponsors:   Azidus Brasil;   Cellavita Pesquisa Científica Ltda
Not yet recruiting - verified August 2017
Posted: Sunday, July 30, 2017 - 19:00
Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn
Condition:   Ocular Corneal Burn
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Biological: placebo
Sponsor:   Guangzhou Saliai Stem Cell Science and Technology Co. Ltd.
Not yet recruiting - verified July 2017
Posted: Monday, July 17, 2017 - 19:00
Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
Conditions:   Spinal Cord Injuries;   Spinal Cord Compression;   Spinal Cord Ischemia;   Spinal Cord Diseases;   Spinal Paralysis;   Paraplegia;   Paraplegia, Spinal;   Paraplegia/Paraparesis;   Paraplegia; Traumatic
Interventions:   Procedure: Paraspinal;   Procedure: Paraspinal EX;   Procedure: Paraspinal VR
Sponsors:   MD Stem Cells;   The Healing Institute
Recruiting - verified July 2017
Posted: Sunday, July 9, 2017 - 19:00
Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: HYNRCS-Allo inj
Sponsors:   Hanyang University Seoul Hospital;   Corestem, Inc.
Recruiting - verified July 2017
Posted: Tuesday, July 4, 2017 - 19:00
SORT OUT X - Combo Stent Versus ORSIRO Stent
Conditions:   Coronary Heart Disease;   Angina Pectoris;   Myocardial Infarction
Interventions:   Device: COMBO;   Device: ORSIRO
Sponsors:   Aarhus University Hospital Skejby;   Biotronik SE & Co. KG;   OrbusNeich
Recruiting - verified July 2017
Posted: Saturday, June 24, 2017 - 19:00
Reducing Assymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients
Condition:   Stroke
Intervention:   Device: TPAD (Tethered Pelvic Assist Device)
Sponsor:   Columbia University
Recruiting - verified June 2017
Posted: Tuesday, June 6, 2017 - 19:00
The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction
Condition:   Cerebral Infarction
Interventions:   Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#);   Drug: Aspirin Tablet
Sponsor:   Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified April 2017
Posted: Monday, May 29, 2017 - 19:00
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
Condition:   Alzheimer's Disease
Interventions:   Biological: human umbilical cord blood derived mesenchymal stem cells;   Other: Normal saline 2mL
Sponsor:   Medipost Co Ltd.
Recruiting - verified May 2017
Posted: Wednesday, May 24, 2017 - 19:00
Micro-Fragmented Adipose Tissue (Lipogems®) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury
Conditions:   Shoulder Pain;   Shoulder Impingement Syndrome;   Rotator Cuff Impingement Syndrome;   Rotator Cuff Tendinitis;   Rotator Cuff Syndrome of Shoulder and Allied Disorders;   Spinal Cord Injuries
Interventions:   Biological: Autologous micro-fragmented adipose tissue;   Device: Lipogems system
Sponsor:   Kessler Foundation
Recruiting - verified May 2017
Posted: Wednesday, May 24, 2017 - 19:00
Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy
Condition:   Non Arteritic Ischemic Optic Neuropathy
Intervention:   Procedure: intravitreal injection of MSV
Sponsors:   Instituto Universitario de Oftalmobiología Aplicada;   University of Valladolid
Not yet recruiting - verified June 2017

Pages